Microcirculation, endothelium and glycocalyx changes associated with the use of milrinone in children with septic

Mauricio Sarta-Mantilla1,2, Jaime Fernández-Sarmiento1,3, Lorena Acevedo1,3

  • 1Department of Pediatrics and Intensive Care, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.

PubMed
Abstract

Insights

Milrinone improves microcirculation in children with septic shock by maintaining capillary density and reducing endothelial glycocalyx degradation. These beneficial effects on microcirculation were more pronounced in younger children, despite inflammatory responses.

Area of Science:

  • Pediatric critical care medicine
  • Hemodynamics
  • Septic shock management

Background:

  • Traditional septic shock treatment focuses on macrocirculation (blood pressure, cardiac output).
  • Persistent microcirculatory abnormalities (hemodynamic incoherence) despite adequate macrocirculation are linked to increased organ dysfunction and mortality.
  • Evaluating microcirculatory and endothelial glycocalyx changes is crucial for optimizing septic shock management.

Purpose of the Study:

  • To assess microcirculation (flow, capillary density) and endothelial glycocalyx changes in children with septic shock treated with milrinone.
  • To investigate the relationship between these microcirculatory changes and clinical variables, organ dysfunction, and outcomes.
  • To compare microcirculatory effects of milrinone in different age groups.

Main Methods:

  • Prospective cohort study (February 2022 - January 2023) at a university hospital.
  • Sublingual video microscopy used to evaluate capillary density, microvascular flow, and perfused boundary region (PBR) as a marker of glycocalyx thickness.
  • Primary outcome: association between microcirculation/endothelial glycocalyx changes and milrinone use.

Main Results:

  • 140 children included; 57.9% received milrinone.
  • Milrinone recipients maintained functional capillary density and capillary recruitment capacity at 24 hours.
  • Children under two years receiving milrinone showed improved capillary density and less glycocalyx degradation, even with elevated ferritin.
  • Higher PBR levels correlated with mortality; prolonged capillary refill and elevated lactate linked to microcirculation changes.

Conclusions:

  • Milrinone administration in pediatric septic shock is associated with improved microcirculatory parameters.
  • Functional capillary density and capillary recruitment capacity are maintained, with reduced endothelial glycocalyx degradation post-milrinone.
  • These microcirculatory benefits are more significant in younger children (<2 years) and persist despite inflammation.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
422
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343